Cramer Holger, Lauche Romy, Paul Anna, Langhorst Jost, Kümmel Sherko, Dobos Gustav J
Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany
Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.
Integr Cancer Ther. 2015 Jan;14(1):5-15. doi: 10.1177/1534735414550035. Epub 2014 Sep 18.
Many breast cancer patients and survivors experience pain and emotional stress related to their disease, its diagnostic procedures, or treatment. Hypnosis has long been used for the treatment of such symptoms. The aim of this review was to systematically assess the effectiveness of hypnosis in women with breast cancer, breast cancer survivors, and in women undergoing diagnostic breast biopsy.
PubMed, Scopus, the Cochrane Library, PsycINFO, and CAMBASE were screened through February 2014 for randomized controlled trials (RCTs) of hypnosis in women with breast cancer or undergoing diagnostic breast biopsy. RCTs on postmenopausal women without a history of breast cancer were also eligible. Primary outcomes were pain, distress, fatigue, nausea/vomiting, and hot flashes. Safety was defined as secondary outcome measure. Risk of bias was assessed by 2 reviewers independently using the Cochrane Risk of Bias Tool.
Thirteen RCTs with 1357 patients were included. In women undergoing diagnostic breast biopsy (3 RCTs), hypnosis positively influenced pain and distress; 1 RCT on breast cancer surgery found effects of hypnosis on pain, distress, fatigue, and nausea. For women undergoing radiotherapy (3 RCTs), hypnosis combined with cognitive-behavioral therapy improved distress and fatigue. In 3 RCTs on women with and without a history of breast cancer experiencing hot flashes, hypnosis improved hot flashes and distress. Three RCTs on women with metastatic breast cancer found effects on pain and distress.
This systematic review found sparse but promising evidence for the effectiveness of hypnosis in breast cancer care. While more research is needed to underpin these results, hypnosis can be considered as an ancillary intervention in the management of breast cancer-related symptoms.
许多乳腺癌患者及其幸存者会经历与疾病、诊断程序或治疗相关的疼痛和情绪压力。长期以来,催眠疗法一直用于治疗此类症状。本综述的目的是系统评估催眠疗法对乳腺癌女性患者、乳腺癌幸存者以及接受乳腺诊断性活检的女性的有效性。
截至2014年2月,对PubMed、Scopus、Cochrane图书馆、PsycINFO和CAMBASE进行筛选,以查找关于乳腺癌女性患者或接受乳腺诊断性活检的女性的催眠疗法随机对照试验(RCT)。无乳腺癌病史的绝经后女性的RCT也符合要求。主要结局指标为疼痛、痛苦、疲劳、恶心/呕吐和潮热。安全性被定义为次要结局指标。由两名评价者独立使用Cochrane偏倚风险工具评估偏倚风险。
纳入了13项RCT,共1357例患者。在接受乳腺诊断性活检的女性中(3项RCT),催眠疗法对疼痛和痛苦有积极影响;1项关于乳腺癌手术的RCT发现催眠疗法对疼痛、痛苦、疲劳和恶心有效果。对于接受放疗的女性(3项RCT),催眠疗法联合认知行为疗法可改善痛苦和疲劳。在3项针对有或无乳腺癌病史且经历潮热的女性的RCT中发现,催眠疗法可改善潮热和痛苦。3项针对转移性乳腺癌女性的RCT发现其对疼痛和痛苦有效果。
本系统综述发现催眠疗法在乳腺癌护理中的有效性证据虽少但颇具前景。虽然需要更多研究来支持这些结果,但催眠疗法可被视为管理乳腺癌相关症状的辅助干预措施。